Compounds > temozolomide
Page last updated: 2024-11-04

temozolomide and Acromegaly

temozolomide has been researched along with Acromegaly in 2 studies

Acromegaly: A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grasso, LF1
Pivonello, R1
Colao, A1
Morin, E1
Berthelet, F1
Weisnagel, J1
Bidlingmaier, M1
Serri, O1

Reviews

1 review available for temozolomide and Acromegaly

ArticleYear
Investigational therapies for acromegaly.
    Expert opinion on investigational drugs, 2013, Volume: 22, Issue:8

    Topics: Acromegaly; Dacarbazine; Drugs, Investigational; Human Growth Hormone; Humans; Octreotide; Pioglitaz

2013

Other Studies

1 other study available for temozolomide and Acromegaly

ArticleYear
Failure of temozolomide and conventional doses of pegvisomant to attain biochemical control in a severe case of acromegaly.
    Pituitary, 2012, Volume: 15, Issue:1

    Topics: Acromegaly; Adult; Dacarbazine; Human Growth Hormone; Humans; Male; Temozolomide; Treatment Outcome;

2012